This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ALK To Present At The Deutsche Bank 39th Annual Health Care Conference In Boston

Copenhagen, April 29, 2014 (GLOBE NEWSWIRE) --

R&D and Business Briefing in NYC on 21 May  

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that the Company will present at the Deutsche Bank 39 th Annual Health Care Conference to be held at the InterContinental Boston Hotel in Boston, MA.  

Flemming Pedersen, CFO and EVP, presents the Company and provides an overview of the Company and its key programmes on 8 May 2014 at 10:00 AM EDT. 

On 21 May 2014, ALK will be hosting an R&D and business briefing for institutional investors, equity research analysts and media in New York City. Further details will be available closer to the date. Any questions regarding this event can be directed to Janet Dally at janetdally@maidstonelifesci.com (+1 609-466-0466). Please use this link to register online: https://www.regonline.com/Alkbusinessbriefing  

ALK-Abello A/S 

 

For further information please contact: Investor Relations:Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525Janet Dally, tel. +1 609 466 0466, mobile +1 732 319 2833, e-mail: janetdally@maidstonelifesci.com

Press:Martin Barlebo, tel. +45 4574 7901, mobile +45 2064 1143

About ALK ALK is a research-driven global pharmaceutical company focusing on allergy prevention, diagnosis and treatment. ALK is the world leader in allergy immunotherapy - a unique treatment of the underlying cause of allergy. The company has approximately 1,800 employees with subsidiaries, production facilities and distributors worldwide. ALK has entered into partnership agreements with Merck and Torii to commercialise sublingual allergy immunotherapy tablets in North America and Japan, respectively. The company is headquartered in Hoersholm, Denmark, and listed on NASDAQ OMX Copenhagen. Find more information at www.alk.net.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,691.83 -38.28 -0.22%
S&P 500 2,070.21 -6.57 -0.32%
NASDAQ 4,992.4390 -16.7750 -0.33%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs